A murine model of wheat versus potato allergy: Patatin and 53kDa protein are the potential allergen from potato

Molecular Immunology
Ibtessam Tahir Ansari, Taihua Mu

Abstract

Wheat allergy is the most common around the world as gluten is the potential allergen. People diagnosed with wheat allergy were mainly substitute with other novel food such as potato though it is also being reported for allergenic manifestations. Thus there is an increasing demand for developing a BALB/c mice model to empathize the allergic properties of potato protein and its fractions. Purified potato protein showed lower IgE-binding capacity (474.39 ± 0.6 ng/mL) even in higher concentration (30 mg/mL) compared to wheat gluten (1418.28 ± 0.17 ng/mL, 5mg/mL). Immediate active cutaneous hypersensitivity reaction, vascular leakage, intestinal permeability and lung's inflammatory cell infiltration was also ascertained comparatively lower in potato protein than wheat gluten. Furthermore, patatin (43 kDa) and protease inhibitors (∼21 kDa) were purified and separated, and patatin exhibited higher hypersensitivity score than that of protease inhibitors. Immuno-detection assays indicated that patatin and 53 kDa protein in potato protein showed specific Ig-E binding capacity, and 53 kDa was adenosyl homocysteinase identified by LC-MS/MS.

References

Jan 1, 1978·Advances in Experimental Medicine and Biology·J MesteckyJ L Babb
Jan 1, 1990·International Archives of Allergy and Applied Immunology·R WahlU Wahn
Nov 1, 1989·Allergy·S QuirceE Losada
Oct 1, 1967·The Journal of Allergy·J P Nater, J A Zwartz
Feb 13, 1996·Annals of the New York Academy of Sciences·S Strobel
Sep 1, 1996·Contact Dermatitis·J DelgadoT Carrillo
Apr 2, 1998·European Journal of Biochemistry·A M PotsA G Voragen
Oct 1, 1996·Nature Biotechnology·J D AstwoodR L Fuchs
Jan 20, 1999·The Journal of Allergy and Clinical Immunology·U SeppäläN Kalkkinen
Mar 21, 2000·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·R J DearmanI Kimber
Jul 11, 2000·The Journal of Allergy and Clinical Immunology·X M LiH A Sampson
Feb 24, 2001·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·J L BeausoleilN A Pawlowski
Jul 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·J MattesP S Foster
Dec 14, 2001·The Journal of Allergy and Clinical Immunology·B NiggemannU Wahn
Jul 4, 2003·Current Opinion in Allergy and Clinical Immunology·Kati Palosuo
Apr 17, 2004·European Journal of Clinical Investigation·J G H Ruseler-van EmbdenJ D Laman
May 6, 2004·Current Opinion in Allergy and Clinical Immunology·Léon M J KnippelsAndré H Penninks
May 8, 2004·The Journal of Allergy and Clinical Immunology·Hugh A Sampson
Apr 13, 2005·Gastroenterology·Stephan Bischoff, Sheila E Crowe
Jun 22, 2005·The Journal of Experimental Medicine·Joshua A Boyce, K Frank Austen
Dec 13, 2006·Methods : a Companion to Methods in Enzymology·Rebecca J Dearman, Ian Kimber
Jul 14, 2007·The Journal of Allergy and Clinical Immunology·Roberto J RonaCharlotte Madsen
Feb 13, 2008·International Archives of Allergy and Immunology·Barbara ProustGisèle Kanny
Jan 18, 2011·The Journal of Allergy and Clinical Immunology·Scott H Sicherer
Jun 1, 2011·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·P SotkovskýL Tučková
Aug 27, 2011·Respiratory Research·Berislav BosnjakMichelle M Epstein
Jan 14, 2017·Oncotarget·Rui-Di XiePing-Chang Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.